Bone morphogenetic protein-4 control of pituitary pathophysiology
Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor-β (TGF-β) family, is overexpressed in different prolactinoma models and induces the development of these lineage adenomas. SMAD proteins activated by growth factors of the TGF-β and BMP family interact with estrogen rec...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | SER |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p22_Giacomini |
Aporte de: |
id |
todo:paper_03013073_v35_n_p22_Giacomini |
---|---|
record_format |
dspace |
spelling |
todo:paper_03013073_v35_n_p22_Giacomini2023-10-03T15:18:18Z Bone morphogenetic protein-4 control of pituitary pathophysiology Giacomini, D. Páez-Pereda, M. Theodoropoulou, M. Gerez, J. Nagashima, A.C. Chervin, A. Berner, S. Labeur, M. Refojo, D. Renner, U. Stalla, G.K. Arzt, E. bone morphogenetic protein bone morphogenetic protein 4 corticotropin retinoic acid transforming growth factor beta transforming growth factor beta receptor animal biological model conference paper cytology gene expression growth, development and aging human hypophysis hypophysis disease metabolism nerve cell physiology secretion Adrenocorticotropic Hormone Animals Bone Morphogenetic Proteins Gene Expression Humans Models, Biological Neurons Pituitary Diseases Pituitary Gland Receptors, Transforming Growth Factor beta Transforming Growth Factor beta Tretinoin Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor-β (TGF-β) family, is overexpressed in different prolactinoma models and induces the development of these lineage adenomas. SMAD proteins activated by growth factors of the TGF-β and BMP family interact with estrogen receptors to stimulate the proliferation of prolactin and growth hormone-secreting cells. Furthermore, BMP-4 presents differential expression in normal and adenomatous corticotropes and inhibitory action on corticotropinoma cell proliferation. Moreover, BMP-4 mediates the antiproliferative action of retinoic acid in these cells. The present review highlights not only the crucial and opposite role of BMP-4 in the progression of pituitary adenomas but also that BMP-4 and retinoic acid interaction might serve as a potential new mechanism target for therapeutic approaches for Cushing disease. Copyright © 2006 S. Karger AG. Fil:Giacomini, D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Páez-Pereda, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Gerez, J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Labeur, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Refojo, D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. SER info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p22_Giacomini |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
bone morphogenetic protein bone morphogenetic protein 4 corticotropin retinoic acid transforming growth factor beta transforming growth factor beta receptor animal biological model conference paper cytology gene expression growth, development and aging human hypophysis hypophysis disease metabolism nerve cell physiology secretion Adrenocorticotropic Hormone Animals Bone Morphogenetic Proteins Gene Expression Humans Models, Biological Neurons Pituitary Diseases Pituitary Gland Receptors, Transforming Growth Factor beta Transforming Growth Factor beta Tretinoin |
spellingShingle |
bone morphogenetic protein bone morphogenetic protein 4 corticotropin retinoic acid transforming growth factor beta transforming growth factor beta receptor animal biological model conference paper cytology gene expression growth, development and aging human hypophysis hypophysis disease metabolism nerve cell physiology secretion Adrenocorticotropic Hormone Animals Bone Morphogenetic Proteins Gene Expression Humans Models, Biological Neurons Pituitary Diseases Pituitary Gland Receptors, Transforming Growth Factor beta Transforming Growth Factor beta Tretinoin Giacomini, D. Páez-Pereda, M. Theodoropoulou, M. Gerez, J. Nagashima, A.C. Chervin, A. Berner, S. Labeur, M. Refojo, D. Renner, U. Stalla, G.K. Arzt, E. Bone morphogenetic protein-4 control of pituitary pathophysiology |
topic_facet |
bone morphogenetic protein bone morphogenetic protein 4 corticotropin retinoic acid transforming growth factor beta transforming growth factor beta receptor animal biological model conference paper cytology gene expression growth, development and aging human hypophysis hypophysis disease metabolism nerve cell physiology secretion Adrenocorticotropic Hormone Animals Bone Morphogenetic Proteins Gene Expression Humans Models, Biological Neurons Pituitary Diseases Pituitary Gland Receptors, Transforming Growth Factor beta Transforming Growth Factor beta Tretinoin |
description |
Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor-β (TGF-β) family, is overexpressed in different prolactinoma models and induces the development of these lineage adenomas. SMAD proteins activated by growth factors of the TGF-β and BMP family interact with estrogen receptors to stimulate the proliferation of prolactin and growth hormone-secreting cells. Furthermore, BMP-4 presents differential expression in normal and adenomatous corticotropes and inhibitory action on corticotropinoma cell proliferation. Moreover, BMP-4 mediates the antiproliferative action of retinoic acid in these cells. The present review highlights not only the crucial and opposite role of BMP-4 in the progression of pituitary adenomas but also that BMP-4 and retinoic acid interaction might serve as a potential new mechanism target for therapeutic approaches for Cushing disease. Copyright © 2006 S. Karger AG. |
format |
SER |
author |
Giacomini, D. Páez-Pereda, M. Theodoropoulou, M. Gerez, J. Nagashima, A.C. Chervin, A. Berner, S. Labeur, M. Refojo, D. Renner, U. Stalla, G.K. Arzt, E. |
author_facet |
Giacomini, D. Páez-Pereda, M. Theodoropoulou, M. Gerez, J. Nagashima, A.C. Chervin, A. Berner, S. Labeur, M. Refojo, D. Renner, U. Stalla, G.K. Arzt, E. |
author_sort |
Giacomini, D. |
title |
Bone morphogenetic protein-4 control of pituitary pathophysiology |
title_short |
Bone morphogenetic protein-4 control of pituitary pathophysiology |
title_full |
Bone morphogenetic protein-4 control of pituitary pathophysiology |
title_fullStr |
Bone morphogenetic protein-4 control of pituitary pathophysiology |
title_full_unstemmed |
Bone morphogenetic protein-4 control of pituitary pathophysiology |
title_sort |
bone morphogenetic protein-4 control of pituitary pathophysiology |
url |
http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p22_Giacomini |
work_keys_str_mv |
AT giacominid bonemorphogeneticprotein4controlofpituitarypathophysiology AT paezperedam bonemorphogeneticprotein4controlofpituitarypathophysiology AT theodoropouloum bonemorphogeneticprotein4controlofpituitarypathophysiology AT gerezj bonemorphogeneticprotein4controlofpituitarypathophysiology AT nagashimaac bonemorphogeneticprotein4controlofpituitarypathophysiology AT chervina bonemorphogeneticprotein4controlofpituitarypathophysiology AT berners bonemorphogeneticprotein4controlofpituitarypathophysiology AT labeurm bonemorphogeneticprotein4controlofpituitarypathophysiology AT refojod bonemorphogeneticprotein4controlofpituitarypathophysiology AT renneru bonemorphogeneticprotein4controlofpituitarypathophysiology AT stallagk bonemorphogeneticprotein4controlofpituitarypathophysiology AT arzte bonemorphogeneticprotein4controlofpituitarypathophysiology |
_version_ |
1807314658914205696 |